XRCC6P5: A Potential Drug Target and Biomarker for X-ray Damage

Target Name: XRCC6P5

NCBI ID: G442459

XRCC6P5

Other Name(s): X-ray repair cross complementing 6 pseudogene 5 | LOC442459 | X-ray repair complementing defective repair pseudogene

XRCC6P5: A Potential Drug Target and Biomarker for X-ray Damage

Introduction

X-ray exposure is a common cause of DNA damage, leading to the development of various diseases such as cancer, cardiovascular diseases, and neurodegenerative disorders. Damage to DNA can result in the loss of genetic material, which can lead to the development of these diseases. Therefore, it is crucial to identify and target the processes that cause DNA damage to prevent the development of these diseases. One of the promising targets for the treatment of DNA damage is XRCC6P5, a pseudogene located on chromosome 6 that has been shown to play a crucial role in the repair of x-ray-induced DNA damage.

In this article, we will discuss the potential drug target and biomarker of XRCC6P5, its function in DNA repair, and the current research on its potential as a drug target.

Function of XRCC6P5

XRCC6P5 is a pseudogene located on chromosome 6 that has been shown to encode a protein that plays a crucial role in the repair of DNA damage caused by x-rays. The protein encoded by XRCC6P5 is composed of 156 amino acids and has a calculated molecular weight of 19.9 kDa.

XRCC6P5 functions as a DNA repair protein by promoting the formation of a double-stranded DNA repair template in the damaged region. The protein binds to the site of damage and helps to recruit the necessary repair components, leading to the formation of a double-stranded repair template. The template is then used by the DNA repair system to repair the damaged DNA.

XRCC6P5 has been shown to be involved in the repair of various types of DNA damage caused by x-rays, including ionizing radiation and thermal stress. In addition, the protein has been shown to play a role in the regulation of cell cycle progression and has been shown to interact with various cellular signaling pathways, including the T-cell signaling pathway.

Potential Drug Target

XRCC6P5 has been identified as a potential drug target due to its involvement in the repair of DNA damage caused by x-rays. The use of x-rays as a form of radiation therapy is a common treatment for various types of cancer and has been shown to be effective in the treatment of these diseases. However, radiation therapy can cause DNA damage, which can lead to the development of various diseases, including cancer. Therefore, targeting the processes that cause DNA damage, such as XRCC6P5, could lead to the development of more effective and less toxic treatments for radiation-induced DNA damage.

In addition, the role of XRCC6P5 in the regulation of cell cycle progression and its interaction with various cellular signaling pathways make it an attractive target for small molecule inhibitors. These inhibitors could be used to treat various types of cancer, including breast, ovarian, and colorectal cancers.

Biomarker

XRCC6P5 has also been identified as a potential biomarker for the detection and treatment of DNA damage caused by x-rays. The protein has been shown to be expressed in various tissues and has been used as a marker for the diagnosis of radiation-induced DNA damage . In addition, the protein has been shown to be involved in the regulation of cellular processes, including cell cycle progression and DNA repair, making it an attractive target for the development of biomarkers for the detection and treatment of DNA damage.

Conclusion

XRCC6P5 has been shown to play a crucial role in the repair of DNA damage caused by x-rays. Its function as a DNA repair protein makes it an attractive target for the development of drugs that target the processes that cause DNA damage. In addition, the protein has also been shown to be a potential biomarker for the detection and treatment of DNA damage. Further research is needed to

Protein Name: X-ray Repair Cross Complementing 6 Pseudogene 5

The "XRCC6P5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about XRCC6P5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets